Skip to content
Home/Companies/Biotech/Cour Pharmaceuticals
CP

Cour Pharmaceuticals

Biotech·United States·Active·3yr hold

Cour Pharmaceuticals is a biotech company, headquartered in United States.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Cour Pharmaceuticals?

Cour Pharmaceuticals is currently owned by Angelini Ventures through Angelini Ventures (2022 vintage), since 2023.

Hand-verified · updated 2026-07-26

Angelini Ventures
Investor
Angelini Ventures
Angelini Ventures · 2022 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Angelini Ventures

Other portfolio companies in the same fund.

Handspring Health
Active
HealthTechUnited States· 2026
Hypervision Surgical
Active
MedTechUnited Kingdom· 2026
Adcytherix
Active
BiotechFrance· 2025
Elkedonia
Active
BiotechFrance· 2025
Laigo Bio
Active
BiotechNetherlands· 2025
Nobi
Active
MedTechBelgium· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings